Zuo et al. demonstrated the inhibitory action on EMT activation in prostate cancer (PCa) PC-3 cells 33, which was confirmed by EMT markers including N-cadherin, fibronectin, vimentin and ZEB1. The gene discussed is ZEB1; the disease is prostate carcinoma.